<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92398">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01867554</url>
  </required_header>
  <id_info>
    <org_study_id>C12-06</org_study_id>
    <secondary_id>2012-A00936-37</secondary_id>
    <nct_id>NCT01867554</nct_id>
  </id_info>
  <brief_title>Research and Characterization of New Genes Involved in Intellectual Disability</brief_title>
  <acronym>GeneDefi</acronym>
  <official_title>Recherche et caractérisation de Nouveaux gènes impliqués Dans la déficience Intellectuelle.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <authority>France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intellectual disability (ID) occurs in 2 to 3 % of the general population but the cause is
      identified only in 30 to 60% of cases.

      The purpose of this study is to indentify genes involved in ID with new genetics tools
      (SNP-arrays, next generation sequencing...) and establish genotype-phenotype correlations.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Number of participants with genetic cause identified</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of participants for which the causative gene of intellectual disability will be identified and number of genes involved in intellectual disability identified with new technologies including microarray and next generation sequencing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>genotype-phenotype correlations</measure>
    <time_frame>genotype-phenotype correlations (according to the genes identified in a period of 5 years)</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Explore genotype-phenotype correlations when a new gene involved in intellectual disability will be identified</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">8500</enrollment>
  <condition>Intellectual Disability</condition>
  <arm_group>
    <arm_group_label>Intellectual disability</arm_group_label>
    <description>patients with intellectual disability or psycho-motor retardation and their parents and sibs (affected or not)</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>gene analysis</intervention_name>
    <description>gene analysis</description>
    <arm_group_label>Intellectual disability</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA RNA Plasma Urines
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        -  2500 patients with intellectuel disability

          -  5000 parents or unaffected sibs

          -  1000 affected sibs
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  for the patients: Clinical diagnosis of intellectual disbility

          -  for the unaffected sibs: to be aged at least 3 years

          -  informed consent

        Exclusion Criteria:

          -  absence of informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexis Brice, MD</last_name>
    <role>Study Director</role>
    <affiliation>Institut National de la Santé Et de la Recherche Médicale, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Delphine Heron, MD</last_name>
    <phone>+33 1 42 16 13 47</phone>
    <email>delphine.heron@psl.aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CRICM - UPMC/Inserm UMR_S975/CNRS UMR7225, Groupe Hospitalier de la Pitié-Salpêtrière,</name>
      <address>
        <city>Paris</city>
        <zip>750013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delphine Heron, MD</last_name>
      <phone>+33 1 42 16 13 47</phone>
      <email>delphine.heron@psl.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Delphine Heron, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Nava C, Lamari F, Héron D, Mignot C, Rastetter A, Keren B, Cohen D, Faudet A, Bouteiller D, Gilleron M, Jacquette A, Whalen S, Afenjar A, Périsse D, Laurent C, Dupuits C, Gautier C, Gérard M, Huguet G, Caillet S, Leheup B, Leboyer M, Gillberg C, Delorme R, Bourgeron T, Brice A, Depienne C. Analysis of the chromosome X exome in patients with autism spectrum disorders identified novel candidate genes, including TMLHE. Transl Psychiatry. 2012 Oct 23;2:e179. doi: 10.1038/tp.2012.102.</citation>
    <PMID>23092983</PMID>
  </results_reference>
  <verification_date>October 2012</verification_date>
  <lastchanged_date>June 3, 2013</lastchanged_date>
  <firstreceived_date>January 28, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intellectual disability</keyword>
  <keyword>Autism spectrum disorders</keyword>
  <keyword>gene</keyword>
  <keyword>Next generation sequencing</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Mental Retardation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
